According to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.

Trump announced a 10% tariff on all U.S. trading partners, in addition to higher reciprocal tariffs on the EU and China. But ...

Many investor eyes were on the pharmaceutical industry on Tuesday, and not necessarily for the right reasons. The Trump ...

Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...

Former Pharmexcil director emphasizes caution and long-term strategies for Indian pharma industry amid US tariff exemptions.

US President Trump has exempted Indian pharmaceuticals from new reciprocal tariffs, benefiting India's pharmaceutical sector.

The pharmaceutical industry isn’t happy about President Donald Trump’s trade war and is reportedly lobbying the President to slow down drug ...

Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon ...

Pharmaceutical products will be spared from sweeping tariffs on major U.S. trade partners for now, a small victory for drug companies who have been lobbying for an exemption from levies.

US President Donald Trump has again singled out Ireland's pharmaceutical industry as a target for tariffs. Trump was speaking ...

India's pharmaceutical sector has been exempted by the US from the reciprocal tariffs. The country exports USD 8.7 billion ...

Europe's pharmaceutical sector is bracing for the potential impact of U.S. tariffs as hopes of an industry-wide exemption by President Donald Trump fade.